iShares Evolved U.S. Innovative Healthcare ETF
IEIH
IEIH was delisted on the 22nd of August, 2022.
18 hedge funds and large institutions have $13.2M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
39% more capital invested
Capital invested by funds: $9.52M → $13.2M (+$3.7M)
13% more funds holding
Funds holding: 16 → 18 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Truist Financial
Charlotte,
North Carolina
|
+$1.82M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$838K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$216K |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$58.4K |
| 5 |
PIMG
Patriot Investment Management Group
Knoxville,
Tennessee
|
+$27.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$306K |
| 2 |
AWS
Atria Wealth Solutions
New York
|
-$66.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$38.6K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$33 |
IEIH Hedge Fund Activity: Q2 2022 in Review
18 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q2 2022, worth a combined $13.2M — up 39% from $9.52M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IEIH positions and 2 closed out — a net gain of 2 holders — while 7 added to existing stakes and 3 trimmed.
The largest buyer was Truist Financial, opening a new position worth an estimated $1.82M. The largest seller was Susquehanna International Group, cutting an estimated $306K.
- 18 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q2 2022, up from 16 in Q1 2022.
- Funds reported $13.2M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q2 2022, up 39% quarter-over-quarter.
- 4 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q2 2022 and 2 closed out, a net change of +2 holders.
- The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q2 2022 was Truist Financial, an estimated $1.82M added.
- The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q2 2022 was Susquehanna International Group, an estimated $306K sold.
Based on aggregated 13F filings for Q2 2022.